Drawing for INNOVADERM

USPTO serial 79423252

INNOVADERM

Reviewed by CopyMark Law Group

Reg. 8017009Status 700Registered
Filing date
Status date
Registration date
Nov 11, 2025
Examiner
BLAZICH, JOAN MICHELE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INNOVADERM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles G. Zug

Charles G. Zug Nelson Mullins Riley & Scarborough LLP301 S. College St.Suite 2300, IP DepartmentCharlotte, NC 28202

Goods and services

ClassDescriptionStatusFirst use
035Collection of data for business purposes in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; collection and compilation of data in computer databases in the field of preclinical and nonclinical research, clinical trials and other studies.ACTIVE—
042Scientific and medical research in the nature of conducting clinical trials for others; scientific research and development in the fields of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; medical and scientific research, namely, designing of protocols for organizing, conducting, monitoring and managing preclinical and non-clinical research, clinical trials, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products for others; medical and scientific research consulting services for others in the field of preclinical and non-clinical research, clinical trials, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; calibration, scientific analysis and electronic storage of data in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; scientific and medical research services, namely, providing research assistance services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; scientific research and analysis in the fields of data management and biostatistics; scientific and medical research services, namely, analyzing and providing of information and data in the fields of preclinical and nonclinical research, clinical trials, other studies, research assistance services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; providing scientific and medical research information in the field of preclinical and nonclinical scientific research, clinical trials and other clinical and technical studies.ACTIVE—
044Information, advisory and consultancy services in the field of medical clinic services; medical clinic services; medical clinics; medical testing services in relation to subjects in clinical trials of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic productsACTIVE—
045Regulatory compliance consulting and advisory services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 7, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 7, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 18, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 31, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 30, 2026FIMPFINAL DISPOSITION PROCESSED—
Feb 11, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 25, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 18, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 18, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 18, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2025RFNTREFUSAL PROCESSED BY IB—
Jul 8, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 8, 2025RFRRREFUSAL PROCESSED BY MPU—
May 13, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2025DOCKASSIGNED TO EXAMINER—
May 9, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 9, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance